IL6 and non-small cell lung carcinoma: In addition to the induction of CD14, we assessed to what extent IL-6, M-CSF, and BLM-CM induce comparable phenotypes in CD14+ cDC2s by measuring the functional and immune regulatory markers we found for CD14+ cDC2s in NSCLC (Figure 1C).